Table 1.
VC Coverage | Drug Regimen (Coverage) | Yangwen 1st | Yangwen 2nd | Yangwen 3rd | Yangwen 4th | Sungisun | Hseihchuang | Lakshadweep | Karaikal | Little Kinmen | Kwemwale/Nkumba | Miton |
---|---|---|---|---|---|---|---|---|---|---|---|---|
VC 0% | DEC Salt (60%) | 0.5 | 0.7 | 0.7 | 0.7 | 0.6 | 0.7 | 1.1 | 0.7 | 0.7 | 2.4 | 2.0 |
DEC Salt (80%) | 0.4 | 0.6 | 0.5 | 0.6 | 0.5 | 0.6 | 0.9 | 0.5 | 0.6 | 1.9 | 1.6 | |
DEC Salt (100%) | 0.3 | 0.4 | 0.4 | 0.5 | 0.4 | 0.5 | 0.8 | 0.4 | 0.5 | 1.6 | 1.4 | |
Annual IDA (80%) | 4.1 | 4.3 | 4.2 | 4.3 | 4.2 | 4.3 | 4.2 | 3.5 | 4.2 | 3.9 | 4.0 | |
Annual MDA (80%) | 6.5 | 6.7 | 6.6 | 6.5 | 6.3 | 6.7 | 6.5 | 5.6 | 6.3 | 5.7 | 5.9 | |
Biannual MDA (80%) | 2.8 | 3.0 | 2.8 | 2.9 | 2.8 | 2.9 | 2.9 | 2.3 | 2.9 | 2.7 | 2.8 | |
VC 50% | DEC Salt (60%) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.5 | 0.2 | 0.1 | 0.4 |
DEC Salt (80%) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.4 | 0.2 | 0.1 | 0.3 | |
DEC Salt (100%) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.1 | 0.3 | |
Annual IDA (80%) | 1.2 | 1.2 | 1.3 | 1.2 | 1.1 | 1.4 | 1.3 | 3.0 | 1.4 | 1.0 | 1.9 | |
Annual MDA (80%) | 2.5 | 2.4 | 2.5 | 2.4 | 2.2 | 2.7 | 2.6 | 5.0 | 2.6 | 1.7 | 3.0 | |
Biannual MDA (80%) | 0.8 | 0.8 | 0.8 | 0.7 | 0.6 | 0.9 | 0.8 | 1.9 | 0.9 | 0.5 | 1.0 | |
VC 80% | DEC Salt (60%) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.5 | 0.2 | 0.1 | 0.4 |
DEC Salt (80%) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.4 | 0.1 | 0.1 | 0.3 | |
DEC Salt (100%) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.3 | 0.1 | 0.1 | 0.3 | |
Annual IDA (80%) | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.3 | 1.3 | 2.9 | 1.3 | 1.0 | 1.7 | |
Annual MDA (80%) | 2.4 | 2.4 | 2.5 | 2.4 | 2.2 | 2.6 | 2.5 | 4.9 | 2.5 | 1.6 | 2.9 | |
Biannual MDA (80%) | 0.8 | 0.7 | 0.8 | 0.7 | 0.6 | 0.9 | 0.8 | 1.9 | 0.8 | 0.5 | 1.0 |
The estimated mean number of years required to reduce mf prevalence to the 95% probability mf breakpoint threshold under each intervention in a particular site are reported.